Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial
about
Preservation of the intercostobrachial nerve during axillary node clearance for breast cancerLocoregional treatment of early breast cancer with isolated tumor cells or micrometastases on sentinel lymph node biopsyGaps between Evidence and Practice in Postoperative Radiotherapy for Prostate Cancer: Focus on Toxicities and the Effects on Health-Related Quality of LifeTargeted therapies with companion diagnostics in the management of breast cancer: current perspectivesOncologic safety of conservative mastectomy in the therapeutic settingAxillary surgery in women with sentinel node-positive operable breast cancer: a systematic review with meta-analysesPostmastectomy radiation therapy after neoadjuvant chemotherapy: review and interpretation of available dataNew trends in breast cancer surgery: a therapeutic approach increasingly efficacy and respectful of the patientSentinel Lymph Node in Breast Cancer: Review Article from a Pathologist's Point of ViewLandmark trials affecting the surgical management of invasive breast cancerMapping lymph nodes in cancer management - role of (99m)Tc-tilmanocept injectionMain controversies in breast cancerOptimal management of breast cancer in the elderly patient: current perspectivesModulating the extension of axillary lymphadenectomy for early stage breast cancerManagement of Axilla in 2015 in Indian ScenarioAxillary treatment for operable primary breast cancer.Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013The Noninvasive Treatment for Sentinel Lymph Node Metastasis by Photodynamic Therapy Using Phospholipid Polymer as a Nanotransporter of VerteporfinLocal treatment of the axilla in early breast cancer: concepts from the national surgical adjuvant breast and bowel project B-04 to the planned intergroup sentinel mamma trialSurvival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trialNovel rapid-immunohistochemistry using an alternating current electric field for intraoperative diagnosis of sentinel lymph nodes in breast cancer.Clinically node negative breast cancer patients undergoing breast conserving therapy, sentinel lymph node procedure versus follow-up: a Dutch randomized controlled multicentre trial (BOOG 2013-08).Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases: commentary on the IBCSG 23-01 Trial.Advances in managing breast cancer: a clinical updateClinical outcomes after sentinel lymph node biopsy in clinically node-negative breast cancer patients.Sentinel Node Biopsy Alone versus Completion Axillary Node Dissection in Node Positive Breast Cancer: Systematic Review and Meta-Analysis.Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Towards optimal management of the axilla in the context of a positive sentinel node biopsy in early breast cancerNew concepts in axillary management of breast cancerER-poor and HER2-positive: a potential subtype of breast cancer to avoid axillary dissection in node positive patients after neoadjuvant chemo-trastuzumab therapy.Meeting highlights: the first korean breast cancer treatment consensus conference.Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trialSentinel lymph node biopsy in breast cancer: a work in progress.Axillary lymph node management in breast cancer with positive sentinel lymph node biopsy.Breast cancer and sentinel lymph node micrometastases: indications for lymphadenectomy and literature reviewPrediction of macrometastasis in axillary lymph nodes of patients with invasive breast cancer and the utility of the SUV lymph node/tumor ratio using FDG-PET/CTEffect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials.Axillary dissection can be avoided in the majority of clinically node-negative patients undergoing breast-conserving therapySentinel node biopsy and axillary dissection in breast cancer: the evidence and its limits.Controversial indications for sentinel lymph node biopsy in breast cancer patients.
P2860
Q24194111-B3C7E104-89AA-41C2-873F-FD3EC167AB32Q26747688-F633E38A-CD1C-44BA-A091-70948F9B2664Q26751574-0D948A68-A914-4194-AAAA-B729D4C81E95Q26768119-68FE2DF8-2C8F-409B-A6F8-BCF87CCE025CQ26768209-265FCC68-6BDD-4AE6-A99C-B2F152D62EC7Q26768675-4ABEB02E-E4DD-4C03-BB35-35EEB7D82877Q26769835-9D18E484-4243-4784-8F81-BD59C4FA9153Q26771845-8CC71BC9-E8E4-4FCC-B5E6-E8EF517A4C87Q26772240-D7940983-9EA3-4F8F-B1E9-612B852E1BB6Q26830129-ED389F28-C356-4E87-9F91-A2F98B55BCA6Q27022042-CBA7CC00-0633-47B9-9171-C8193F5E7F0DQ27026673-D02D5F27-252E-4046-896F-D024B92D94D6Q27690879-C10377DE-39B5-4E99-9929-647EF845C409Q28073247-15E4E004-2D44-427B-9691-69452B8038C7Q28079495-061902F0-FDF7-48B7-B9F1-28B1976834D1Q30239832-544AB23D-E442-4981-B96B-524E59D237AAQ30543788-8869F161-0FC5-4F56-BE68-F9E5C7E90DF0Q33572096-5C0F9CE7-3214-4FFC-B0BC-69AE07932E32Q33684856-18377456-53DD-48CE-86CE-A16F29963D16Q33733790-07F84DA1-847C-4DA2-977E-97C5FBDB4E2BQ33765728-D893F7B8-9D34-4557-812B-1FACE51E5BEFQ33862578-2B27ED69-0EB9-415B-B6D0-34E640355C4FQ33973078-DB8FE714-A5CB-4138-9188-3DB94D4B6A80Q34019904-58F0232C-832B-4BAD-ACB8-4C14D780CE0EQ34325446-59B796C0-EF08-47C8-96E7-2309A4C9E4A1Q34425423-E171F417-4596-4636-8601-801EE8FFBAC5Q34655579-318FC852-3A94-4C30-9A80-C938AD2B9239Q34657647-DF61BF2F-44E2-4415-960F-453E68FFB0C9Q34657725-D1A7EDF2-63DA-4212-A2B5-28C1C29E8295Q34680978-387E99E2-87EC-4694-A399-1D525E4F2323Q34779593-FC10DACD-6AFD-4247-81D0-5F3F61CBF3F6Q34919537-80B97DC7-594C-4EA2-A2EA-D30C6FF981F5Q35005848-C94935BC-C197-48AE-A380-8E429BAA7EE9Q35054490-7DC17808-2245-4106-AD9F-ED2CAFAC984BQ35063285-CEE115C0-DAAB-4CB4-AE1F-FA500EC48F42Q35108597-90B82AD4-3381-49EA-B054-F866DB7FB031Q35127637-AF24F5BD-8455-49E2-B117-0ECD089AF8D2Q35147064-0F5B772D-5BBE-47EA-A430-4413982DD423Q35157554-6E043EDD-1D7F-4734-AE0F-76704CB2496EQ35187754-36390894-0C59-44B0-A1F5-9EE8E11D2E5C
P2860
Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 March 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Axillary dissection versus no ...... 3 randomised controlled trial
@en
Axillary dissection versus no ...... sentinel-node micrometastases
@nl
type
label
Axillary dissection versus no ...... 3 randomised controlled trial
@en
Axillary dissection versus no ...... sentinel-node micrometastases
@nl
prefLabel
Axillary dissection versus no ...... 3 randomised controlled trial
@en
Axillary dissection versus no ...... sentinel-node micrometastases
@nl
P2093
P2860
P1433
P1476
Axillary dissection versus no ...... 3 randomised controlled trial
@en
P2093
Alan S Coates
Alberto Luini
Angelo Recalcati
Aron Goldhirsch
Bernard F Cole
Camelia Chifu
David Littlejohn
Giovanni Mazzarol
Hanne Galatius
International Breast Cancer Study Group Trial 23-01 investigators
P2860
P304
P356
10.1016/S1470-2045(13)70035-4
P577
2013-03-11T00:00:00Z